EUVIMEDEUVIMED entdecken
Open Access

OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis

Christina Mayerhofer, Dan Li, Trine Kristiansen, Ernst Mayerhofer, Azeem Sharda, Giulia Schiroli, Karin Gustafsson, Lingli He, Michael Mazzola, Sam Keyes, Anna Kiem, Eve Crompton und 8 weitere

Cell Metabolism · 2025-10 · 37 (10) · 2014-2029.e9

DOI: 10.1016/j.cmet.2025.08.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2025-10. Verfasst von Christina Mayerhofer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative Medicine and Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Harvard Stem Cell Ins…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Protein Biosynthesis, Drug Resistance, Neoplasm, Dioxygenases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) commonly relapses after initial chemotherapy response. We assessed metabolic adaptations in chemoresistant cells in vivo before overt relapse, identifying altered branched-chain amino acid (BCAA) levels in patient-derived xenografts (PDXs) and immunophenotypically identified leukemia stem cells from AML patients. Notably, this was associated with increased BCAA transporter expression with low BCAA catabolism. Restricting BCAAs further reduced chemoresistant AML cells, but relapse still occurred. Among the persisting cells, we found an unexpected increase in protein production. This was accompanied by elevated translation of 2-oxoglutarate- and iron-dependent oxygenase 1 (OGFOD1), a known ribosomal dioxygenase that adjusts the fidelity of tRNA anticodon pairing with coding mRNA. We found that OGFOD1 upregulates protein synthesis in AML, driving disease aggressiveness. Inhibiting OGFOD1 impaired translation processing, decreased protein synthesis and improved animal survival even with chemoresistant AML while sparing normal hematopoiesis. Leukemic cells can therefore persist despite the stress of chemotherapy and nutrient deprivation through adaptive control of translation. Targeting OGFOD1 may offer a distinctive, translation-modifying means of reducing the chemopersisting cells that drive relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProtein BiosynthesisDrug Resistance, NeoplasmDioxygenasesNutrientsStress, PhysiologicalHumansAnimalsMiceAmino Acids, Branched-ChainCell Line, TumorFemale

Stichwörter der Autor:innen

BCAAOGFOD1Ribo-seqacute myeloid leukemiachemoresistancemetabolismprotein biosynthesisribosome pausingtranslation accuracy

Substanzen

Amino Acids, Branched-ChainDioxygenasesNutrients

Autor:innen und Institutionen

  • Center for Regenerative Medicine and Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard Univ…
  • Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Center for Regenerative Medicine and Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
  • Center for Regenerative Medicine and Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Harvard Center for Mass Spectrometry, Harvard University, Cambridge, MA, USA.
  • Center for Regenerative Medicine and Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambri…

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health
  • Deutsche Forschungsgemeinschaft
  • Vetenskapsrådet
  • National Cancer Institute
  • Dana-Farber Cancer Institute

Zitieren

APA

Mayerhofer, C., Li, D., Kristiansen, T., Mayerhofer, E., Sharda, A., Schiroli, G., Gustafsson, K., He, L., Mazzola, M., Keyes, S., Kiem, A., Crompton, E., Xu, Y., Korm, S., Dou, Z., Vidoudez, C., Miller, P. G., van Gastel, N., Graubert, T. A., & Scadden, D. T. (2025). OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis. Cell Metabolism, 37(10), 2014-2029.e9. https://doi.org/10.1016/j.cmet.2025.08.008

Vancouver

Mayerhofer C, Li D, Kristiansen T, Mayerhofer E, Sharda A, Schiroli G, et al. OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis. Cell Metabolism. 2025;37(10):2014-2029.e9. doi:10.1016/j.cmet.2025.08.008

BibTeX
@article{Mayerhofer2025,
  author = {Mayerhofer, Christina and Li, Dan and Kristiansen, Trine and Mayerhofer, Ernst and Sharda, Azeem and Schiroli, Giulia and Gustafsson, Karin and He, Lingli and Mazzola, Michael and Keyes, Sam and Kiem, Anna and Crompton, Eve and Xu, Yanxin and Korm, Sovannarith and Dou, Zhixun and Vidoudez, Charles and Miller, Peter G and van Gastel, Nick and Graubert, Timothy A and Scadden, David T},
  title = {OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis},
  journal = {Cell Metabolism},
  year = {2025},
  volume = {37},
  number = {10},
  pages = {2014--2029.e9},
  doi = {10.1016/j.cmet.2025.08.008}
}
Kostenlos starten →